Updated 'My MS Manager' Mobile App Helps People With MS Manage Their Disease Better

The app is a convenient tool for individuals living with Multiple Sclerosis to store important medical information, track symptoms and disease activity.

My MS Manager, a mobile phone app created by the Multiple Sclerosis Association of America (MSAA) to help people with Multiple Sclerosis (MS) to manage their disease better, now offers new features to connect and share information with their physician.

The app is available for Apple and Android mobile devices for free. The app is a convenient tool for individuals living with MS to store important medical information, track symptoms and disease activity; generate charts and reports across various metrics such as treatments, moods, symptoms and more.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

My MS Manager app has the ability to connect physicians and members of the healthcare team via the app to share the progress and reports securely.

My MS Manager Ambassador Anna Webber states, "In this world that is increasingly powered by all-things-digital, efficiency and clarity are at the top of my list. Having been diagnosed with MS as a 23-year-old, I wanted to do my best to take control of my health. Having a tool to help me do this has been extremely helpful. The Multiple Sclerosis Association of America’s mobile app, My MS Manager, allows me to not only keep track of all of my notes, meds, doctor info, labs, and journals, but also gives me access to local resources, current MS research updates, and so much more. I can now manage my disease with an incredible amount of clarity and efficiency – things I have not had before. A huge thank you to MSAA, for giving me the tools to be in control."

Source-Medindia

Walk Event for Multiple Sclerosis in Kentucky, United States
MS walk event to raise funds to fight Multiple Sclerosis and provide services to help those affected by Multiple Sclerosis live their best lives.

Lemtrada Shows Reduced Relapse Of Multiple Sclerosis Compared to Standard Drug
The Lemtrada drug demonstrated the reduction in relapse rates over 2 years and might also reduce progression of Multiple Sclerosis.

Chemical Compound That Decreases Effects of Multiple Sclerosis Identified
Multiple sclerosis (MS), an autoimmune disease of the brain and spinal cord, affects about 2.3 million people worldwide.